Literature DB >> 30954716

A case of immune thrombocytopaenia induced by pembrolizumab in a metastatic melanoma patient with a history of immune-mediated pure red cell aplasia.

Mathilde Berger1, Mona Amini-Adlé1, Laura Crumbach1, Etienne Paubelle2, Stéphane Dalle3.   

Abstract

Entities:  

Keywords:  Immune checkpoint blocking agents; Immune related adverse events; Immunotherapy; Melanoma; PD1-inhibitor; Pure red cell aplasia; Thrombocytopaenia

Year:  2019        PMID: 30954716     DOI: 10.1016/j.ejca.2019.02.006

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  2 in total

1.  Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitors in Solid Cancer: Case Report and Literature Review.

Authors:  Xiaolin Liu; Xiuju Liang; Jing Liang; Yan Li; Jun Wang
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

Review 2.  Immune Thrombocytopenia Induced by Immune Checkpoint Inhibitrs in Lung Cancer: Case Report and Literature Review.

Authors:  Wang Xie; NaNa Hu; LeJie Cao
Journal:  Front Immunol       Date:  2021-12-09       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.